Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Amortization of Deferred Charges (2021 - 2023)

AVITA Medical filings provide 3 years of Amortization of Deferred Charges readings, the most recent being $86000.0 for Q4 2023.

  • On a quarterly basis, Amortization of Deferred Charges rose 1.18% to $86000.0 in Q4 2023 year-over-year; TTM through Dec 2023 was $341000.0, a 63.94% increase, with the full-year FY2023 number at $341000.0, up 0.89% from a year prior.
  • Amortization of Deferred Charges hit $86000.0 in Q4 2023 for AVITA Medical, up from $85000.0 in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $86000.0 in Q4 2023 to a low of -$46000.0 in Q2 2022.
  • Median Amortization of Deferred Charges over the past 3 years was $85000.0 (2022), compared with a mean of $69181.8.
  • Biggest five-year swings in Amortization of Deferred Charges: plummeted 157.5% in 2022 and later soared 284.78% in 2023.
  • AVITA Medical's Amortization of Deferred Charges stood at $82000.0 in 2021, then rose by 3.66% to $85000.0 in 2022, then increased by 1.18% to $86000.0 in 2023.
  • The last three reported values for Amortization of Deferred Charges were $86000.0 (Q4 2023), $85000.0 (Q3 2023), and $85000.0 (Q2 2023) per Business Quant data.